Stock ALNY ALNYLAM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Alnylam Pharmaceuticals, Inc.

Equities

ALNY

US02043Q1076

Market Closed - Nasdaq
Other stock markets
 21:30:00 03/05/2024 BST 		5-day change 1st Jan Change
152.3 USD +1.34% Intraday chart for Alnylam Pharmaceuticals, Inc. +6.29% -20.42%
05-02 Alnylam Pharmaceuticals' Q1 Non-GAAP Net Loss Narrows as Revenue Increases; 2024 Outlook Affirmed MT
05-02 Transcript : Alnylam Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 19.27B -
MODERNA, INC. Stock Moderna, Inc.
 47.9B -
LONZA GROUP AG Stock Lonza Group AG
 41.42B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 40.7B
CELLTRION, INC. Stock Celltrion, Inc.
 28.92B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 25.55B
  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. Charts Alnylam Pharmaceuticals, Inc.
  5. Sector Chart